Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population
Christopher Blaum(Universität Hamburg), Christoph Waldeyer(Universität Hamburg), Alina Goßling, Friederike Kröger, Tanja Zeller(Universität Hamburg), Dirk Westermann(University Medical Center Freiburg), Julian Braetz, Francisco Ojeda(Universidad Complutense de Madrid), Moritz Seiffert(Universität Hamburg), Mahir Karakas(Universität Hamburg), Lukas Koester, Renate B. Schnabel(Universität Hamburg), Stefan Blankenberg(Universität Hamburg), Fabian J. Brunner, Thiess Lorenz(Universität Hamburg)
Cited by 57
Related Papers
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Epidemiology of Atrial Fibrillation in the 21st Century
|Circulation Research|2020|1.5k
New loci associated with kidney function and chronic kidney disease
|Nature Genetics|2010|809